Skip to main content
. 2017 Mar 6;8:234. doi: 10.3389/fimmu.2017.00234

Figure 2.

Figure 2

Cumulative incidence of (A) death-censored graft survival and (B) patient survival in recipients of an ABO-incompatible (ABOi) living donor graft and matched controls receiving an ABO-compatible (ABOc) living donor graft [updated Figure 1 of Ref. (15)]. (C) Cumulative incidence of death-censored graft survival in recipients of an ABOi living donor graft with and without anti-CD20 antibody treatment [updated Figure 4 of Ref. (15)]. (D) Cumulative incidence of death due to infection in recipients of an ABOi living donor graft and matched controls receiving an ABOc living donor graft [updated Figure 3 of Ref. (15)].